1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,582 | 0,604 | 13:03 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.09. | Lifecare ASA: Mandatory notification of trade | - | Oslo Børs | ||
| 24.09. | Lifecare ASA: Lifecare strengthens miniaturisation roadmap with new patent applications | 1 | Oslo Børs | ||
| LIFECARE ASA Aktie jetzt für 0€ handeln | |||||
| 15.09. | Lifecare ASA: LIFECARE RESUBMITS APPLICATION FOR FIRST-IN-HUMAN CLINICAL STUDY | 1 | Oslo Børs | ||
| 27.08. | Lifecare ASA: Reconfirmed positive results in veterinary study support path toward market entry | 3 | Oslo Børs | ||
| 20.08. | LIFE: Lifecare ASA Q2 2025 results | 4 | Oslo Børs | ||
| 13.08. | Lifecare ASA: Lifecare advances CE mark preparation for its groundbreaking medical device | 4 | Oslo Børs | ||
| 12.08. | Lifecare ASA: Invitation to presentation of Q2 2025 results 20 August at 10.45 CEST | 3 | Oslo Børs | ||
| 05.08. | Lifecare ASA Secures REK Ethics Approval For First-In-Human CGM Trial | 2 | RTTNews | ||
| 05.08. | Lifecare ASA: Lifecare receives ethics approval to initiate first-in-human trial in Norway | 3 | Oslo Børs | ||
| 08.07. | Lifecare ASA: Lifecare achieves full radio frequency compliance for CGM implant clearing the way for CE mark of electronics | 2 | Oslo Børs | ||
| 01.07. | Lifecare ASA: Lifecare advances electromagnetic compatibility compliance testing for CGM implant | 1 | Oslo Børs | ||
| 25.06. | Lifecare ASA: Share capital increase registered | 2 | Oslo Børs | ||
| 13.06. | Lifecare ASA: Final results following expiry of the exercise period for the Warrants issued in connection with the Rights Issue | 2 | Oslo Børs | ||
| 13.06. | Lifecare ASA: Notification of trade - exercise of warrants | - | Oslo Børs | ||
| 13.06. | Lifecare ASA: Last day of the Exercise Period for the Warrants issued in connection with the Rights Issue | 1 | Oslo Børs | ||
| 06.06. | Lifecare ASA: Notification of trade - exercise of warrants | 1 | Oslo Børs | ||
| 06.06. | Lifecare ASA: Last day of trading in the Warrants issued in connection with the Rights Issue | 1 | Oslo Børs | ||
| 02.06. | Lifecare ASA: Exercise price for the Warrants issued in connection with the Right Issue | 3 | Oslo Børs | ||
| 02.06. | Lifecare ASA: Commencement of the Exercise Period for the Warrants issued in connection with the Rights Issue | 2 | Oslo Børs | ||
| 30.05. | Lifecare ASA: Lifecare announces second clinical trial site at Pfützner Science & Health Institute in Mainz, Germany | 1 | Oslo Børs |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 88,69 | +1,27 % | The Roku Streaming Stick Plus drops to only $29 in this Prime Day deal | ||
| SERNOVA BIOTHERAPEUTICS | 0,115 | 0,00 % | Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 82,80 | -0,24 % | Piper Sandler bestätigt 'Overweight'-Rating für Boston Scientific | ||
| PAUL HARTMANN | 223,00 | +0,90 % | Januar bis Juni 2025: PAUL HARTMANN behauptet sich in herausforderndem Marktumfeld | Heidenheim (ots) - - Umsatzerlöse steigen auf 1.214,0 Mio. EUR, organisches Umsatzwachstum von 1,6 % - Bereinigtes EBITDA liegt bei 125,8 Mio. EUR, bereinigte EBITDA-Rendite bei 10,4 % - Transformationsprogramm... ► Artikel lesen | |
| SYSMEX | 10,600 | +0,95 % | Dividendenbekanntmachungen (29.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1777 EUR ACOM CO LTD JP3108600002 10 JPY 0,0572 EUR ADVANTEST CORPORATION JP3122400009 19... ► Artikel lesen | |
| ADDLIFE | 15,800 | -1,86 % | AddLife AB: Interim Report January 1 - June 30, 2025 | Continued improvement in margins and profit"The companies within AddLife continue to develop in line with our priorities. Margins are strengthening in both business areas thanks to continuous development... ► Artikel lesen | |
| EMBECTA | 12,400 | 0,00 % | Dividendenbekanntmachungen (29.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACNB CORPORATION US0008681092 0,34 USD 0,2911 EUR ADVANCED DRAINAGE SYSTEMS INC US00790R1041 0,18 USD 0,1541 EUR AEBI SCHMIDT HOLDING... ► Artikel lesen | |
| ENOVIS | 27,200 | -0,73 % | Enovis Corporation: Enovis Announces Second Quarter 2025 Results | Continued commercial momentum with second-quarter sales growth of 7% on a reported basisSecond-quarter Reconstructive sales grew 11% year-over-year on a reported basis Wilmington, DE, Aug. 07, 2025... ► Artikel lesen | |
| KANGJI MEDICAL | 1,000 | +1,52 % | KANGJI MEDICAL (09997): JOINT ANNOUNCEMENT - MONTHLY UPDATE IN RELATION TO (1) PROPOSAL FOR THE PRIVATISATION OF KANGJI MEDICAL HOLDINGS LIMITED BY THE ... | ||
| PULMONX | 1,420 | +2,90 % | Pulmonx korrigiert Umsatzprognose nach unten - US-Geschäft schwächelt | ||
| KOOTH | 1,650 | +3,12 % | Kooth inks contract with New Jersey for further year under same terms | ||
| SI-BONE | 12,300 | 0,00 % | SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance | Second Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $48.6 million, representing growth of 21.7%U.S. revenue of $46.4 million, representing... ► Artikel lesen | |
| PEIJIA MEDICAL | 0,710 | 0,00 % | Peijia Medical Announces 2025 Interim Results | HONG KONG, Aug. 25, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets... ► Artikel lesen | |
| BACTIGUARD | 1,645 | -5,46 % | BACTIGUARD HOLDING AB: Independent studies expand clinical evidence on Bactiguard's technology in orthopedics | ||
| SCIBASE | 0,010 | -68,52 % | SciBase: Nevisense Used in Fundamental Skin Barrier Research on Atopic Dermatitis | STOCKHOLM, Sept. 26, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, announced today the publication... ► Artikel lesen |
Das Unternehmen LIFECARE ASA kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -6,15 % bei einem Aktienkurs von 0,610 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFECARE ASA finden Sie auf Wallstreet Online.